NEW YORK, March 20, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Citigroup, Inc. (NYSE: C), JPMorgan Chase & Co. (NYSE: JPM), Morgan Stanley (NYSE: MS), State Street Corp. (NYSE: STT), and NorthStar Realty Finance Corp. (NYSE: NRF). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
--
Citigroup, Inc. Analyst Notes
On March 14, 2014, Citigroup, Inc. (Citi) announced that it will issue the press release of its Q1 2014 results on April 14, 2014, at 8:00 a.m. ET. Further, the results will be reviewed via live webcast and teleconference at 11:00 a.m. ET on the same day. Citi stated that the earnings press release, webcast and presentation materials will be available at its website, where a replay and transcript of the webcast will also be made available shortly after the event. The full analyst notes on Citigroup, Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03202014/C/report.pdf
--
JPMorgan Chase & Co. Analyst Notes
On March 14, 2014, JPMorgan Chase & Co. (JPMorgan Chase) declared dividends on two of its preferred stock issues. The Company announced dividends in the amount of $395.00 per share (equivalent to $39.50 per related Depositary Share) on its Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series I; and in the amount of $257.50 per share (equivalent to $25.75 per related Depositary Share) Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series Q. JPMorgan Chase informed that the Series I dividend is payable on April 30, 2014, to stockholders of record as of the close of business on March 31, 2014, and that the Series Q dividend is payable on May 1, 2014, to Company stockholders of record as of the close of business on April 1, 2014. The full analyst notes on JPMorgan Chase & Co. are available to download free of charge at:
http://www.AnalystsReview.com/03202014/JPM/report.pdf
--
Morgan Stanley Analyst Notes
On March 11, 2014, Morgan Stanley announced that it has appointed Lisa M. Cregan as the Mid-Atlantic Regional Director for Morgan Stanley Wealth Management, based in Washington, D.C. According to the Company, the region includes six complexes and 40 branch offices stretching from Northern Virginia to Northern Ohio. Cregan will report to Richard Skae, Northeast Division Director, who said, "Lisa Cregan is an accomplished leader - passionate about serving clients, developing the professional skills of our people and advancing women in finance. She will do an excellent job leading our Mid-Atlantic Region." The full analyst notes on Morgan Stanley are available to download free of charge at:
http://www.AnalystsReview.com/03202014/MS/report.pdf
--
State Street Corp. Analyst Notes
On March 10, 2014, State Street Corp. (State Street) announced that two of its senior executives, Suresh Krishnamurthy and Cesar Estrada, have been appointed to its Alternatives Investment Solutions' (AIS) North American Private Equity Fund Services team, and will lead teams dedicated to servicing alternative fund of funds, limited partner, direct and hybrid structures. According to the Company, both are senior managing directors and will report to Bhagesh Malde, Head of Private Equity and Real Estate Fund Services for North America and Asia Pacific. Commenting on the appointments, Malde stated, "We're focused on providing dedicated teams and sophisticated data and analytics tools to help managers satisfy these growing demands, boost performance and manage risk more effectively. Cesar and Suresh's teams will focus on supporting our clients as they adapt to this changing environment." The full analyst notes on State Street Corp. are available to download free of charge at:
http://www.AnalystsReview.com/03202014/STT/report.pdf
--
NorthStar Realty Finance Corp. Analyst Notes
On March 17, 2014, NorthStar Realty Finance Corp. (NorthStar) announced that it has entered into a definitive agreement to acquire a $1.05 billion healthcare real estate portfolio from investment partnerships owned and managed by Formation Capital, LLC or its affiliated entities and Safanad Limited. According to NorthStar, the portfolio consists of 43 primarily private-pay senior housing facilities and 37 skilled nursing facilities with approximately $1.6 billion healthcare real estate portfolio consisting of over 160 properties. Commenting on the agreement, David Hamamoto, Chairman and CEO of NorthStar, stated, "We are very pleased to have a diversified, quality portfolio of healthcare properties added to our existing healthcare portfolio that we expect will produce attractive current and overall returns. Since joining our healthcare real estate team only two months ago, Jay Flaherty has sourced an investment pipeline through his relationships in the industry that is adding significant value to the NorthStar franchise." The full analyst notes on NorthStar Realty Finance Corp. are available to download free of charge at:
http://www.AnalystsReview.com/03202014/NRF/report.pdf
--
About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
--
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute
SOURCE Analysts Review
